Novel remedies for cancer
AssigneeSumitomo Pharmaceuticals Company, Limited
InventorsToshihiro Noguchi, Akemi Baba, Mitsuharu Hanada
Life of this patent
Estimating the term…
Abstract
A medicament for treating cancer for use in combination therapy with an anti-HER2 antibody, which comprises amrubicin or a pharmaceutically acceptable salt thereof as an active ingredient.
Claims25
A medicament for treating cancer for use in combination therapy with an anti-HER2 antibody, which comprises amrubicin or a pharmaceutically acceptable salt thereof as an active ingredient.
Use of amrubicin or a pharmaceutically acceptable salt thereof for manufacturing a medicament for treating cancer which is administered in combination with an anti-HER2 antibody.
A method of treating cancer comprising using an effective amount of an anti-HER2 antibody and an effective amount of amrubicin or a pharmaceutically acceptable salt thereof in combination.
A kit for treating cancer comprising a first composition including amrubicin or a pharmaceutically acceptable salt thereof and a second composition including an anti-HER2 antibody.
Dependencies are inferred from the claim text.